4.4 Letter

FCγRIIIA and FCγRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma

Journal

HAEMATOLOGICA
Volume 92, Issue 7, Pages 998-999

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.10327

Keywords

Fc gamma R; single nucleotide polymorphism; rituximab; chemotherapy; diffuse large B-cell lymphoma

Categories

Funding

  1. Croatian Ministry of Science [108007]

Ask authors/readers for more resources

We investigated the association of Fc gamma RIIIa and Fc gamma RIIa polymorphisms and response to R-CHOP in 58 patients with diffuse large B-cell lymphoma (DLBCL). Fc gamma RIIIa and Fc gamma RIIa polymorphisms did not influence response, event-free or overall survival. These results suggest that ADCC via Fc gamma RIIIa and Fc gamma RIIa may not be the major mechanism of activity of the R-CHOP combination in DLBCL.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available